Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/ChiCTR2100045458
ChiCTR2100045458Active, not recruitingPhase 4

术前右旋美托咪定口服对全麻应激的影响

自筹1 site in 1 country100 target enrollmentStarted: May 7, 2021Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Phase 4
Status
Active, not recruiting
Sponsor
Enrollment
100
Locations
1
Primary Endpoint
镇静评分
Study OverviewStudy DesignEligibility CriteriaArms & InterventionsOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

右旋美托咪定作为术前药是否可以替代传统术前药并减轻全麻诱发应激反应。

Study Design

Study Type
干预性研究
Primary Purpose
随机平行对照
Masking
未说明

Eligibility Criteria

Ages
18 to 70 (—)
Sex
All

Inclusion Criteria

  • •全麻气管插管患者，年龄 18 岁~70 岁（含 18 岁和 70 岁，男性或女性）。

Exclusion Criteria

  • •患者存在严重脏器功能不良或损害；
  • •窦性心动过缓，心率<50bpm；
  • •垂体肿瘤，术前激素水平异常，口服激素治疗者；
  • •多次手术史者（≥3 次）。

Arms & Interventions

对照组

无术前药

右旋美托咪定组

术前口服右美

Outcomes

Primary Outcomes

镇静评分

促肾上腺皮质激素

皮质醇

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
自筹

Study Sites (1)

Loading locations...

Similar Trials

Unknown
Not Applicable
右美托咪定复合全麻对围术期应激反应的影响
ChiCTR-IPR-17012237研究生课题40
Unknown
Not Applicable
右旋美托咪啶对开胸手术病人全麻苏醒期应激反应和术后镇痛的影响
ChiCTR-TRC-12001934自筹60
Unknown
Not Applicable
右美托咪定对患者术后睡眠质量及患者血清皮质醇、5-HT 和 hypocretin 的影响
ChiCTR2100051598自筹1,000
Unknown
Not Applicable
不同剂量右美托咪定联合舒芬太尼用于手术后静脉镇痛患者安全性及有效性研究
ChiCTR-IPD-16009745国家自然科学基金2,400
Unknown
Not Applicable
术前夜低剂量右美托咪定连续输注对术后恢复质量的影响
ChiCTR1900020712福建省立医院科研基金160